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Abstract: Very few studies have examined the association between light cigarette smoking
(i.e., ≤5 cigarettes per day) and mortality. The aim of this study was to examine the association of
light cigarette smoking with all-cause and cause-specific mortality among adults in the United States.
Data were from 13 waves of the National Health Interview Survey (1997 to 2009) that were linked to
the National Death Index records through December 31, 2011. A total of 329,035 participants aged
≥18 years in the United States were included. Deaths were from all cause, cancer, cardiovascular
disease (CVD) and respiratory disease and were confirmed by death certification. During a median
follow-up of 8.2 years, 34,862 participants died, of which 8415 were from cancer, 9031 from CVD,
and 2040 from respiratory disease. Compared with never-smokers, participants who smoked 1–2
(hazard ratios (HR) = 1.94, 95%CI = 1.73–2.16) and 3–5 cigarettes (HR = 1.99, 1.83–2.17) per day were
at higher risk of all-cause mortality after adjustment for demographic variables, lifestyle factors and
physician-diagnosis of chronic disease. The associations were stronger for respiratory disease-specific
mortality, followed by cancer-specific mortality and CVD-specific mortality. For example, the HRs
(95% CIs) of smoking 1–2 cigarettes per day were 9.75 (6.15–15.46), 2.28 (1.84–2.84) and 1.93 (1.58–2.36),
respectively, for these three cause-specific mortalities. This study indicates that light cigarette smoking
increases risk of all-cause and cause-specific mortality in US adults.
Keywords: light smoking; mortality; prospective
1. Introduction
Cigarette smoking is a global public health issue [1,2] with about 5 million deaths each year
attributable to smoking [3]. In the United States (U.S.), the prevalence of cigarette smoking among
adults has declined from 20.9% in 2005 to 16.8% in 2014, [4] mainly due to effective tobacco-control
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policies [5]. However, the risk of deaths from cigarette smoking continues to increase among U.S.
adults, especially among men [6].
Evidence from the National Health Interview Survey (NHIS) suggests that among daily cigarette
smokers, the percentage who smoked less than 10 cigarettes per day increased from 16% to 27% from
2005 to 2014 [4]. In addition, it is believed that such a low level of smoking exposure might be safe
among 10% of U.S. adolescents [7]. Nevertheless, light smoking status is common among smokers who
are trying to quit and may be maintained for many years during their lifetime [8,9]. In line, previous
studies have suggested light smoking isassociated with increased risk of cancer [10,11], coronary
heart disease [12] and stroke. However, limited studies have examined the association between light
smoking and risk of mortality [13–15]. In addition, participants in most of these studies were either
not nationally representative [13–15], restricted to male workers [13] or of older age (≥59 years) [14],
thus limiting the generalizability of the findings. Importantly, the harmfulness of light smoking has
not been given full attention in samples of the general public.
Therefore, we used baseline data from the NHIS collected between 1997 and 2009 linked to data
from the National Death Index (NDI) in 2011 to examine the association of cigarette smoking with
all-cause and cause-specific mortality among U.S. adults aged ≥18 years.
2. Materials and Methods
2.1. Study Population
The NHIS is a nationally representative survey of the civilian, noninstitutionalized U.S. population.
Detailed information of the NHIS has been described elsewhere [16]. In brief, the NHIS is a
cross-sectional survey that has been conducted by the National Center for Health Statistics of the
Centers for Disease Control and Prevention since 1957. NHIS uses a stratified, multistage randomized
sampling design to collect information using personal household interviews. One sample adult is
randomly selected from each household for a detailed interview on health and lifestyle behaviors.
NHIS data are de-identified and do not include any protected health information. The data are publicly
available and exempt under the ethical board review of the corresponding author’s institution.
As the survey questions of the NHIS underwent major revision in 1997, this study is restricted to
NHIS data collected from 1997 to 2009. A total of 366,376 participants aged ≥18 years were included in
the preliminary study. Of these, 37,341 were excluded because of missing data on cigarette smoking
(n = 4301), missing data on covariates (i.e., demographic variables, lifestyle factors and history of
physical-diagnosed diseases; n = 28,859) or were pregnant (n = 4181), leading to a final sample of
329,035 participants.
2.2. Mortality Outcomes
All NHIS participants aged ≥18 years from 1997 to 2009 were linked to the NDI records through
December 31, 2011, using a probabilistic matching algorithm to determine mortality status [17].
Validation studies have shown that the information on deaths in the NDI records was accurate and in
nearly perfect agreement (98.5%) [18,19]. Participants not matched with a death record by December 31,
2011 were considered alive. According to the International Classification of Diseases 10th Revision
(ICD-10) codes, study outcomes were defined as: (1) all-cause mortality; (2) CVD-specific mortality
(codes I00 to I09, I11, I13, I20 to I51and I60 to I69); (3) heart disease-specific mortality (codes I00 to I09,
I11, I13 and I20 to I51); (4) cerebrovascular disease-specific mortality (codes I60 to I69); (5) cancer-specific
mortality (codes C00 to C97); and (6) chronic lower respiratory diseases (codes J40 to J47).
2.3. Cigarette Smoking
We used NHIS participants’ responses to two questions to define their smoking status (never,
former and current smoking): (1) “Have you smoked at least 100 cigarettes in your ENTIRE LIFE?”
(yes vs. no) and (2) “Do you NOW smoke cigarettes?” (yes vs. no). According to the responses to
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these two questions, we categorized participants as never (responded “No” to both questions), former
(responded “Yes” to the first question, “No” to the second question) and current smoking (responded
“Yes” to the second question). Current smokers were asked “How many cigarettes do you smoke a
day?”.Similar with previous publications [13–15], we categorized cigarette smoking status into “never”,
“former”, “1–2 cigarettes per day”, “3–5 cigarettes per day”, “6–10 cigarettes per day”, “11–20 cigarettes
per day”, “21–30 cigarettes per day” and “>30 cigarettes per day”. In this study, participants who
consumed≤5 cigarettes per day were considered as light cigarette smokers [7].
2.4. Covariates
Demographic variables included sex, age, race or ethnicity (White, Black, Hispanic and others),
education level (less than high school, high school and beyond high school), marital status (married;
divorced, separated or widowed; and never married). Lifestyle variables included body mass index
(BMI, weight divided by height squared, kg/m2), physical activity ((PA) whether or not the participants
achieved at least 75 min of vigorous PA or 150 min of moderate PA in one week according to the
Physical Activity Guidelines for Americans [20])) and drinking status (lifetime abstainer, former drinker,
current light to moderate drinker (1–7 drinks per week for women and 1–14 drinks per week for men)
and current heavy drinker (>1 drinks per day for women and >2 drinks per day for men [21,22])).
Clinical variables included self-reported physician diagnoses of hypertension, heart disease, stroke,
cancer or diabetes.
2.5. Statistical Analysis
Differences in baseline participant characteristics between eight categories of cigarette smoking
status (never, former smoker, 1–2, 3–5, 6–10, 11–20, 21–30, >30 cigarettes per day) were tested using
Chi-square test for categorical variables.
Cox proportional hazards regression model was used to estimate the hazard ratios (HRs) and
95% confidence intervals (CIs) of cigarette smoking status with all-cause and cause-specific mortality,
adjusted for potential covariates. The statistical models were sequentially adjusted for covariates
to assess for confounding. Model 1 adjusted for demographic factors (sex, age, race or ethnicity,
education level, marital status). Model 2 additionally adjusted for lifestyle factors (BMI, PA, alcohol
consumption). Model 3 additionally adjusted for clinical variables (history of physician-diagnosed
diseases). Both data pooling and meta-analyses were used to calculate summary HRs and 95% CIs.
We also examined the association between cigarette smoking status and all-cause mortality by
sex, age group and race/ethnicity. Additionally, in sensitivity analyses, (1) participants with a history
of physician-diagnosed diseases were excluded because sick individuals were more likely to quit
smoking; (2) individuals who died within the first 2 years (i.e., a 2-year lag) were excluded because the
deaths were unlikely caused by smoking within short duration; (3) as the missing data accounted for
9.1% (33,160/366,376) in the total population, multiple imputation for variables with missing values
were performed.
To quantitatively evaluate the dose-response association of number of cigarettes per day
(as a continuous variable) with all-cause and cause-specific mortality, we performed Cox proportional
hazards regression models with penalized splines [23], where the reference value assigned was
“never smoking”, using R software v3.3.3 (R Foundation for Statistical Computing, Vienna, Austria),
outputting figures with log HR for all-cause and cause-specific mortality on the y-axis and current
number of cigarettes per day on the x-axis.
Survey weights, strata and cluster in the NHIS design were considered in our data analysis.
A two-sided p < 0.05 was considered statistically significant. All data analyses were performed using
SAS version 9.3 (SAS Institute Inc., Cary, North Carolina, USA) and R software v3.3.3 (R Foundation
for Statistical Computing, Vienna, Austria).
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3. Results
The baseline data included 329,035 U.S. adults. Of these, 72,580 were former cigarette smokers
(22.1%) and 73,184 were current cigarette smokers (22.2%). Table 1 displays baseline characteristics
across the eight categories of cigarette smoking status (never, former smoker, 1–2, 3–5, 6–10, 11–20,
21–30 and >30 cigarettes per day). We observed significant differences in all examined characteristics
across the eight categories of cigarette smoking status (all p < 0.001; Table 1).
During a median (interquartile range) follow-up of 8.2 (5.0–11.5) years, 34,862 participants
died, of which 8415 were cancer-specific deaths, 9031 were cardiovascular disease (CVD)-specific
deaths and 2040 were respiratory diseases-specific deaths. There was a dose-dependent association
of number of cigarettes per day with all-cause mortality as well as with cause-specific mortality
(Table 2). Compared with never smokers, those who currently smoked 1–2 cigarettes per day were
at high risk of all-cause mortality (HR = 1.94, 95%CI = 1.73–2.16). The risk was higher among
those who smoked 3–5 cigarettes per day (HR = 1.99, 1.83–2.17). Similar trends were observed for
cause-specific mortality(cancer mortality: 1–2/day: HR = 2.28 (95%CI = 1.84–2.84), 3–5/day: HR = 2.70
(95%CI = 2.27–3.21); CVD mortality: 1–2/day: HR = 1.93 (95%CI = 1.58–2.36), 3–5/day: HR = 1.96
(95%CI = 1.63–2.35); respiratory disease mortality: 1–2/day: HR = 9.75 (95%CI = 6.15–15.46), 3–5/day:
HR = 11.71(95%CI = 8.84–15.52)). (Table 2).
In meta-analysis of the 13 NHIS survey years (Table S1), results were similar with those from
pooled analyses. In sensitivity analyses that excluded participants who died within the first 2 years of
follow-up or after exclusion of participants who self-reported physician diagnosis of chronic diseases
or that based on imputed data, the results were similar to those shown for the pooled analyses
(Tables S2–S4). In the subgroup analyses, the associations tended to be stronger among women, those
of older age, and among whites (Table S5).
Cox models with penalized splines showed that there were curvilinear dose-response associations
of number of cigarettes per day (as a continuous variable) with risk of all-cause mortality
(Figure S1-A), cancer-specific mortality (Figure S1-B), CVD-specific mortality (Figure S1-C) and
respiratory disease-specific mortality (Figure S1-D), with all p < 0.001 for the nonlinear tests.
Compared with never smokers, those who reported any number of cigarettes per day had higher risk
of all-cause and cause-specific mortality.
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Table 1. Baseline Characteristics according to cigarette smoking status, National Health Interview Survey (NHIS), 1997–2009.
Cigarette Smoking Status
p Value
Never Former Smoker
Current Smoker, Cigarettes Per Day
1–2 3–5 6–10 11–20 21–30 >30
N 183,269 72,580 6933 10,288 18,266 27,997 5573 4129
Age, yrs, % <0.0001
18–39 46.7 20.8 59.6 55.8 51.7 44.2 36.2 26.1
40–59 33.9 39.8 30.4 33.3 36.8 42.8 50.3 58.8
≥60 19.5 39.4 10.0 10.9 11.4 13.0 13.4 15.1
Sex, % <0.0001
Men 43.8 57.3 56.6 50.4 46.5 55.2 64.6 71.5
Women 56.2 42.7 43.4 49.6 53.5 44.8 35.4 28.5
Race/ethnicity, % <0.0001
White 66.6 82.1 57.6 58.6 69.3 84.3 91.9 92.0
Black 13.0 7.3 13.6 18.6 16.9 8.4 4.1 4.0
Hispanic 14.5 7.7 23.5 17.5 9.3 4.6 2.4 2.3
Other 5.8 2.9 5.2 5.3 4.4 2.6 1.6 1.7
Education, % <0.0001
<High school 15.2 16.2 20.0 20.0 21.0 21.1 23.5 30.1
High school 25.9 29.5 27.8 30.3 35.7 40.5 41.5 39.9
>High school 58.8 54.3 52.2 49.7 43.3 38.4 35.1 30.0
Marital status, % <0.0001
Married 57.6 67.0 45.9 42.0 43.8 48.9 51.7 55.4
Divorced/separated/widowed 14.9 19.8 14.7 17.7 19.4 21.2 22.6 24.4
Never married 27.5 13.1 39.4 40.3 36.9 29.9 25.7 20.2
BMI category, kg/m2, % <0.0001
<18.5 1.9 1.3 2.1 2.9 3.4 2.8 2.2 2.5
18.5–24.9 39.7 32.2 42.1 43.6 43.8 43.2 39.0 34.8
25.0–29.9 34.6 39.0 34.2 33.8 31.8 33.4 35.7 35.2
≥30.0 23.7 27.5 21.6 19.7 21.0 20.7 23.1 27.6
Physical activity (meeting recommendation), % <0.0001
No 59.2 58.3 56.1 57.4 64.1 66.6 70.3 75.0
Yes 40.8 41.7 43.9 42.6 35.9 33.4 29.7 25.0
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Table 1. Cont.
Cigarette Smoking Status
p Value
Never Former Smoker
Current Smoker, Cigarettes Per Day
1–2 3–5 6–10 11–20 21–30 >30
Drinking, % <0.0001
Lifetime abstainer 32.5 8.9 10.3 10.6 10.6 9.4 7.8 9.2
Former drinker 11.3 23.3 9.0 11.3 14.1 16.3 19.6 22.5
Light to moderate 53.7 62.3 72.4 68.0 65.9 63.0 55.8 50.2
Heavy 2.5 5.5 8.3 10.1 9.4 11.3 16.8 18.1
Physician-diagnosed disease, %
Hypertension 23.0 36.4 18.4 18.8 20.5 21.8 25.8 31.3 <0.0001
Heart disease 9.1 19.6 8.5 8.1 9.5 10.6 11.8 15.5 <0.0001
Stroke 1.8 4.3 1.6 1.9 2.0 2.3 2.7 3.5 <0.0001
Cancer 5.7 12.3 3.9 4.3 5.2 6.4 7.5 8.0 <0.0001
Diabetes 6.0 11.0 5.1 4.5 5.0 5.0 6.3 9.4 <0.0001
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Table 2. Association of cigarette smoking status with risk of all-cause and cause-specific mortality.
Cigarette Smoking Status, Hazard Ratios (HRs), (95% CIs)
Never Former Smoker
Current Smoker, Cigarettes Per Day
1–2 3–5 6–10 11–20 21–30 >30
N 183,269 72,580 6933 10,288 18,266 27,997 5573 4129
All causes
No. of deaths 14,646 12,440 513 827 1626 3171 793 846
Model 1 1 1.36 (1.32–1.40) 1.88 (1.68–2.10) 1.96 (1.79–2.13) 2.04 (1.91–2.16) 2.25 (2.14–2.36) 2.70 (2.48–2.94) 3.49 (3.21–3.80)
Model 2 1 1.45 (1.40–1.49) 1.96 (1.76–2.19) 2.04 (1.87–2.22) 2.09 (1.96–2.22) 2.30 (2.19–2.42) 2.77 (2.54–3.02) 3.54 (3.25–3.85)
Model 3 1 1.34 (1.30–1.38) 1.94 (1.73–2.16) 1.99 (1.83–2.17) 2.05 (1.93–2.18) 2.22 (2.11–2.34) 2.63 (2.40–2.88) 3.34 (3.06–3.64)
Cancer
No. of deaths 2898 3159 121 217 452 1020 262 286
Model 1 1 1.73 (1.64–1.84) 2.28 (1.82–2.84) 2.75 (2.32–3.25) 2.59 (2.31–2.91) 3.50 (3.22–3.81) 4.38 (3.79–5.05) 5.68 (4.91–6.58)
Model 2 1 1.80 (1.69–1.91) 2.29 (1.83–2.85) 2.74 (2.31–3.25) 2.54 (2.27–2.86) 3.43 (3.14–3.75) 4.31 (3.73–4.99) 5.54 (4.79–6.42)
Model 3 1 1.67 (1.56–1.77) 2.28 (1.84–2.84) 2.70 (2.27–3.21) 2.49 (2.22–2.80) 3.29 (3.01–3.60) 4.02 (3.47–4.66) 5.26 (4.54–6.10)
CVD
No. of deaths 4120 3183 121 176 387 683 186 175
Model 1 1 1.23 (1.16–1.30) 1.88 (1.53–2.30) 1.93 (1.60–2.31) 2.33 (2.02–2.68) 2.39 (2.16–2.64) 3.16 (2.65–3.75) 3.59 (3.01–4.29)
Model 2 1 1.34 (1.27–1.43) 2.01 (1.64–2.46) 2.05 (1.70–2.46) 2.47 (2.14–2.85) 2.52 (2.27–2.78) 3.35 (2.81–3.99) 3.73 (3.11–4.48)
Model 3 1 1.21 (1.14–1.28) 1.93 (1.58–2.36) 1.96 (1.63–2.35) 2.40 (2.07–2.77) 2.36 (2.11–2.64) 3.09 (2.56–3.72) 3.46 (2.89–4.15)
Heart disease
No. of deaths 3053 2543 91 136 307 573 159 154
Model 1 1 1.29 (1.21–1.37) 1.76 (1.38–2.24) 1.86 (1.53–2.26) 2.47 (2.10–2.91) 2.53 (2.26–2.83) 3.53 (2.91–4.27) 3.94 (3.26–4.75)
Model 2 1 1.40 (1.32–1.50) 1.89 (1.48–2.40) 1.99 (1.63–2.42) 2.65 (2.24–3.14) 2.69 (2.40–3.02) 3.76 (3.10–4.56) 4.11 (3.39–4.98)
Model 3 1 1.25 (1.17–1.33) 1.83 (1.43–2.33) 1.90 (1.56–2.31) 2.56 (2.16–3.04) 2.51 (2.22–2.84) 3.47 (2.83–4.25) 3.78 (3.12–4.58)
Cerebrovascular disease
No. of deaths 1067 640 30 40 80 110 27 21
Model 1 1 1.07 (0.95–1.20) 2.43 (1.57–3.77) 2.26 (1.51–3.39) 2.02 (1.57–2.59) 1.94 (1.56–2.42) 1.92 (1.26–2.94) 2.39 (1.48–3.88)
Model 2 1 1.19 (1.05–1.35) 2.57 (1.66–3.99) 2.32 (1.55–3.49) 2.04 (1.59–2.63) 1.98 (1.59–2.46) 1.99 (1.30–3.04) 2.44 (1.50–3.97)
Model 3 1 1.10 (0.97–1.24) 2.49 (1.64–3.80) 2.23 (1.49–3.33) 1.99 (1.54–2.57) 1.83 (1.46–2.30) 1.75 (1.13–2.69) 2.35 (1.44–3.81)
Respiratory diseases
No. of deaths 294 1020 32 77 163 298 70 86
Model 1 1 6.66 (5.66–7.84) 9.91 (6.17–15.93) 12.66(9.56–16.77) 15.32(12.22–19.22) 16.57(13.53–20.29) 21.10(15.33–29.04) 35.11(26.10–47.23)
Model 2 1 7.55 (6.39–8.93) 9.97 (6.26–15.89) 12.17(9.19–16.12) 13.92(11.09–17.48) 15.26(12.49–18.64) 20.05(14.56–27.61) 32.38(24.14–43.42)
Model 3 1 6.96 (5.88–8.23) 9.75 (6.15–15.46) 11.71(8.84–15.52) 13.79(10.96–17.35) 14.53(11.86–17.79) 18.52(13.44–25.52) 30.52(22.63–41.15)
Model 1: Adjusted for sex, age, and race/ethnicity, education and marital status. Model 2: Model 1 plus additionally adjusted for body mass index, alcohol intake and physical activity.
Model 3: Model 2 plus additionally adjusted for physician-diagnosed diseases (hypertension, heart disease, stroke, cancer and diabetes).
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4. Discussion
To our knowledge, this is the first nationally representative and large-scale study examining the
association of light cigarette smoking (i.e., ≤5 cigarettes per day)with risk of all-cause and cause-specific
mortality among U.S. adults. Our findings highlight that there is no safe threshold for cigarette
smoking, and effective smoking control programs should be conducted to prevent smoking in the
general population to reduce risk of mortality.
5. Comparison with Previous Studies
Many prospective studies have examined the association of light cigarette smoking with risk of
cancer [10,11] and CVD [12]. The NIH-AARP Diet and Health Study of 238,525 healthy adults aged
≥59 years found that compared with never smokers, smokers who smoked <1 and 1–10 cigarettes
per day were at higher risk of incident cancer [11]. A recent meta-analysis of 141 cohort studies
found that smoking just one cigarette per day increased risk of coronary heart disease and stroke [12].
However, to our knowledge, only few studies have assessed the association of light smoking with risk
of mortality [13–15] and the findings were inconsistent. In 2002, the Copenhagen City Heart Study of
12,149 adults aged ≥30 years showed that smoking less than 3 g of tobacco per day was not associated
with a significantly increased risk of myocardial infarction and all-cause mortality (women: HR = 1.24,
95%CI = 0.79–1.94; men: HR = 1.32, 95%CI = 0.49–3.56). Increased risk seemed to commence from
3 g of tobacco per day [15]. Another prospective study of 25,464 Japanese workers aged 20–61 years
showed there was no significant association between a smoking level of 1–10 cigarettes per day and
all-cause mortality (HR = 1.51, 95%CI = 0.73–2.94) [13]. The nonsignificant associations in the above
two studies could be due to insufficient statistical power in the light smoking groups. Consistent with
our findings, the NIH-AARP Diet and Health Study of 290,215 healthy adults aged ≥59 years found
occasional smokers (participants who smoked less than 1 cigarette per day) were at higher risk of
all-cause mortality (HR = 1.64, 95%CI = 1.07–2.51), as well as several cause-specific mortality outcomes
(e.g., lung cancer-specific mortality and CVD-specific mortality) [14]. In addition, we found that the
younger participants (18–39 years of age) are more likely to be light cigarette smokers than those in
other age categories. This suggests that the younger people are in a more unstable smoking pattern
and possibly on a trajectory where an increase in number of cigarettes is more common than the older
and more established smokers.
6. Public Health Implications
Our findings have several important public health implications. First, our results are consistent
with the 2008 Public-Health-Service-sponsored Clinical Practice Guidelines and the 2010 Surgeon
General’s Report that no risk-free level of cigarette smoking exists, and even 1–2 cigarettes per day is
harmful for health. Thus, it is important that never smokers (especially for young people) should not
try to smoke cigarettes, and current cigarette smokers should stop smoking to obtain substantial health
benefits. Second, the government should disseminate the dangers of light cigarette smoking via social
media. The government should also provide smoking cessation services for current smokers to help
them stop smoking. In addition, health professionals and primary care physicians also should inform
their patients either not to smoke any dose of cigarettes or to completely stop smoking.
7. Study Strengths and Limitations
The main strengths of our study included the very large sample size, relatively longer duration of
follow-up, adjustment for potential confounding factors, the use of several sensitivity analyses to test
the stability of our findings and the generalizability of our results to the US adults. However, several
limitations should be considered. First, information on cigarette smoking was self-reported which
might be subject to recall bias. However, validation studies suggest that self-report data are strongly
correlated with measured levels of cotinine in blood or urine [24]. Second, cigarette smoking status
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was only available at baseline, and the change in cigarette smoking status among participants during
follow-up might have influenced the findings.
8. Conclusions
Our data suggest that light cigarette smoking is associated with higher risk of all-cause and
cause-specific mortality compared with never smokers. These data indicate that there is no safe level of
cigarette smoking. Our data reinforce the importance of quitting programs aimed at current cigarette
smokers across the life-course.
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